BYSI BeyondSpring, Inc.: Earnings per share for the last 12 months

BeyondSpring Pharma (BYSI) - corporate logo

BeyondSpring Inc. (BYSI) relies on an asset-light model, combining global research with outsourced manufacturing, while growth in the supportive therapy segment allows for the optimization of R&D costs. This price chart illustrates the EPS TTM dynamics, which currently stands at 58.80. The firm's environmental profile is limited to a formal office level due to its virtual management format. BeyondSpring Inc. (BYSI) develops combination therapies aimed at enhancing the immune response and minimizing patient harm.

BeyondSpring Pharma (BYSI) Earnings per share for the last twelve months: for the period 02/11/2024 - 11/10/2026

BYSI (BeyondSpring Pharma): analytical breakdowns and indicator data

- price and consensus price forecast:
Market Price beyondspringpharma.com|BYSI - Price Target Chart
- company stock capitalization data:
Market Capitalization BeyondSpring, Inc.|BYSI - Enterprise Value
- book capitalization indicators:
Accounting Value per Share BeyondSpring|BYSI - Company Book Value|Market-to-Book Ratio beyondspringpharma.com|BYSI - Aggregate Company Assets
- company total debt and liquidity indicators:
Debt to Equity BeyondSpring Inc.|BYSI - Long-Term Debt to Equity|Current Liabilities to Capital BeyondSpring Inc|BYSI - Company Aggregate Debts|Debt to Net Assets BeyondSpring, Inc.|BYSI - Company Long-Term Liabilities|Short-Term Debt BeyondSpring|Intermediate Coverage Ratio beyondspringpharma.com
- earnings and market multiples details:
BYSI - Net Income|Future Net Profit BeyondSpring Inc.|BYSI - P/E Multiple|Future Price to Earnings Multiple BeyondSpring, Inc.|BYSI - PEG Multiple|Company Value to EBITDA BeyondSpring, Inc.|BYSI - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year BeyondSpring|BYSI - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth beyondspringpharma.com|BYSI - Earnings per share growth in current year|Net earnings per share change forecast for next year BeyondSpring Inc.
Fundamental company valuation:BYSI beyondspringpharma.com
Flagship merchandise of BeyondSpring

Stress-testing assets requires an analysis of the rolling year net income per share trend, which measures the actual efficiency of business capitalization. For BeyondSpring Inc. (BYSI), whose revenues depend on regulatory decisions in oncotherapy, the YoY TTM EPS growth value serves as an indicator of the commercial success of its developments, allowing fundamental growth to be distinguished from temporary market fluctuations.

Direct competitors

Net earnings per one share for the last twelve months incyte.com|HUTCHMED (HCM) - Earnings per share for the last twelve months|Earnings per share for the last 12 months NUVB|DAWN (Day One Bio) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Monopar Corp (MNPR)|Earnings per share for the last twelve months Inhibrx Biosciences (INBX)|IMAB - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Fennec Pharmaceuticals Inc. FENC|Heron - Earnings per share for the last twelve months|NVCT - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Coherus Biosciences|CRBP: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Cardiff Oncology CRDF|Net earnings per share for the last 12 months BCAB|Net earnings per one share for the last twelve months Lixte Biotechnology Holdings Inc. LIXT|Net earnings per share for the last 12 months CTXR (Citius Pharmaceuticals)|CLRB (Cellectar Corp) - Earnings per share for the trailing year|BioLineRx Ltd. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters CANF (canfite.com)|Aprea - Net earnings per share (EPS TTM)|Earnings per share for the trailing year KZIA (Kazia Therapeutics)|SLXN: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months NuCana (NCNA)|Earnings per share for the last twelve months Chimerix, Inc.|CYCC: Earnings per share for the trailing year|Net earnings per share (EPS TTM) GTHX|Net earnings per share (EPS TTM) Kronos Bio Inc (KRON)|Earnings per share for the last twelve months Kintara KTRA|ONCT (Oncternal Corp) - Earnings per one share for the last 12 months|PRTG: Net earnings per share for the last 12 months